The pulmonary cachexia syndrome: aspects of energy balance

J Congleton - Proceedings of the Nutrition Society, 1999 - cambridge.org
The present paper reviews current knowledge of the pulmonary cachexia syndrome with
reference to chronic obstructive pulmonary disease (COPD). Aspects of incidence, aetiology …

A validation of the National Early Warning Score to predict outcome in patients with COPD exacerbation

LE Hodgson, BD Dimitrov, J Congleton, R Venn… - Thorax, 2017 - thorax.bmj.com
Background The National Early Warning Score (NEWS), proposed as a standardised track
and trigger system, may perform less well in acute exacerbation of COPD (AECOPD). This …

[HTML][HTML] NEWS 2–too little evidence to implement?

LE Hodgson, J Congleton, R Venn, LG Forni… - Clinical …, 2018 - ncbi.nlm.nih.gov
ABSTRACT The Royal College of Physicians (RCP) recently published the National Early
Warning Score 2 (NEWS2), aiming to improve safety for patients with hypercapnic …

Severe acute interstitial pnuemonia and gefitinib

K Sumpter, J Congleton, C Harper-Wynne… - Lung …, 2004 - lungcancerjournal.info
In response to Inoue et al. report of severe acute interstitial pneumonia and gefitinib [1] and
Teramoto et al. subsequent correspondence [2], we would like to report a case of suspected …

Glomus tumour: a rare differential diagnosis of bronchial obstruction in a smoker

L Lang-Lazdunski, A Bille, P Cane… - General thoracic and …, 2012 - Springer
Tracheo-bronchial glomus tumours are rare, usually benign tumours of modified smooth
muscle cells. They commonly present as non-specific respiratory symptoms of cough …

Effect of regular use of high-dose nebulized β2-agonists on resting energy expenditure, weight, and handgrip strength in patients with chronic airflow limitation

J Congleton, MF Muers - Chest, 1998 - Elsevier
Study objectives A proportion of patients with chronic airflow limitation (CAL) have a raised
resting energy expenditure (REE). The mechanism underlying this is not known. The …

Use of short-acting beta agonists in the treatment of asthma across five European countries

P Panagiotis, J Congleton - Drug and Therapeutics Bulletin, 2022 - dtb.bmj.com
Abstract Commentary on: Janson C, Menzies-Gow A, Nan C, et al. SABINA: an overview of
short-acting β2-agonist use in asthma in European countries. Adv Ther. 2020; 37: 1124–35 …

Tobacco industry lobbyists and their health-care clients

NS Hopkinson, J Moxham, H Montgomery, R West… - The Lancet, 2013 - thelancet.com
Tobacco consumption is responsible for 8· 8% of deaths worldwide, 1 but the introduction of
plain pack legislation in Australia, a strategy intended particularly to make smoking less …

Asthma: a disease of variability

J Congleton - Drug and Therapeutics Bulletin, 2021 - dtb.bmj.com
The British Thoracic Society (BTS) 1990 asthma guideline placed inhaled corticosteroids
(ICS) at the cornerstone of asthma management, resulting in marked improvement in asthma …

SARS-CoV-2: Survival in COPD phenotypes

M Pavitt, S Krivinskas, J Congleton, S Hippolyte - 2021 - Eur Respiratory Soc
Aims & objectives: Individuals with COPD have increased risk of severe pneumonia and
poor outcomes when they develop SARS-CoV-2 (Hoffmann 2020). We hypothesised that …